| 000 | 01670 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515132051.0 | ||
| 264 | 0 | _c20080919 | |
| 008 | 200809s 0 0 eng d | ||
| 022 | _a0929-8673 | ||
| 024 | 7 |
_a10.2174/092986708785133022 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDunkel, P | |
| 245 | 0 | 0 |
_aSemicarbazide-sensitive amine oxidase/vascular adhesion protein 1: recent developments concerning substrates and inhibitors of a promising therapeutic target. _h[electronic resource] |
| 260 |
_bCurrent medicinal chemistry _c2008 |
||
| 300 |
_a1827-39 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAlzheimer Disease _xdrug therapy |
| 650 | 0 | 4 |
_aAmine Oxidase (Copper-Containing) _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aAmines _xchemistry |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlood _xmetabolism |
| 650 | 0 | 4 | _aCattle |
| 650 | 0 | 4 |
_aCell Adhesion Molecules _xmetabolism |
| 650 | 0 | 4 |
_aDiabetes Mellitus _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 |
_aMonoamine Oxidase _xchemistry |
| 650 | 0 | 4 |
_aPlasma _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aSemicarbazides _xchemistry |
| 650 | 0 | 4 | _aSubstrate Specificity |
| 700 | 1 | _aGelain, A | |
| 700 | 1 | _aBarlocco, D | |
| 700 | 1 | _aHaider, N | |
| 700 | 1 | _aGyires, K | |
| 700 | 1 | _aSperlágh, B | |
| 700 | 1 | _aMagyar, K | |
| 700 | 1 | _aMaccioni, E | |
| 700 | 1 | _aFadda, A | |
| 700 | 1 | _aMátyus, P | |
| 773 | 0 |
_tCurrent medicinal chemistry _gvol. 15 _gno. 18 _gp. 1827-39 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/092986708785133022 _zAvailable from publisher's website |
| 999 |
_c18165318 _d18165318 |
||